Organization Overview
Alternative names
ammonia n-13 (2007 NDA)
fludeoxyglucose f-18 (2005)
fluorodopa (fluorodopa F18) (2019 NDA)
sodium fluoride (18F) (2014)
abiraterone (zytiga) (2 trials)
acetaminophen (tylenol) (1 trial)
azathioprine (imuran) (1 trial)
belimumab (benlysta) (1 trial)
carboplatin (paraplatin) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
daratumumab (darzalex) (1 trial)
diphenhydramine (benadryl) (1 trial)
Adrenal Hyperplasia, Congenital (Phase 2)
Adrenocortical Hyperfunction (Phase 2)
Adrenogenital Syndrome (Phase 2)
Alzheimer Disease (Phase 2)
Anemia (Phase 2)
Anemia, Diamond-Blackfan (Phase 2)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Astrocytoma (Phase 2)
Ear Diseases (Phase 2)
Glioblastoma (Phase 2)
Huntington Disease (Phase 2)
Hyperplasia (Phase 2)
Labyrinth Diseases (Phase 2)
Labyrinthitis (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lupus Nephritis (Phase 2)
Metabolic Syndrome (Phase 4)
Nephritis (Phase 2)
Neurilemmoma (Phase 1)
Neuroma, Acoustic (Phase 1)
Obesity, Abdominal (Phase 4)
Parkinson Disease (Phase 1)
Red-Cell Aplasia, Pure (Phase 2)
Syndrome (Phase 4)
Telangiectasia, Hereditary Hemorrhagic (Phase 2)
Telangiectasis (Phase 2)